Skip to main content

Table 7 Efficacy parameters

From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

 

BM-MSC arm

Placebo

 
 

Baseline

6 months

Baseline

6 months

Difference

P value

Rest pain (Median)

3

1

3

0

−1.00

0.1099*

ABPI Mean (SD)

0.554 (0.26)

0.768 (0.15)

0.592 (0.23)

0.596 (0.14)

−0.17

0.0018

  1. *Kruskal-Wallis test.
  2. ANOVA.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us